Company Information
Medibank Private Limited (ASX: MPL)
Medibank Private Limited is a health company based in Australia that specializes in private health insurance and health-related services. The company operates primarily through two brands, Medibank and ahm, offering a variety of health insurance products. Its Health Insurance segment provides both hospital and ancillary coverage. Hospital cover ensures that members have financial support for various hospital treatments while ancillary cover is for other healthcare services like dental, optical, and physiotherapy.
Alongside insurance, Medibank’s Health segment offers health management and home care services, as well as telehealth services across Australia. It caters not only to individuals but also has agreements with government and corporate clients. Additionally, Medibank extends its product range by distributing travel, life, and pet insurance policies, which are provided by other insurers.
In terms of financials, Medibank has generated 7.81 billion AUD in revenue and a net income of 621 million AUD. The company was founded in 1997 and employs around 3,240 people. It has recently completed the acquisition of MyHealth Medical Holdings Pty Ltd.
Top Australian Brokers
- City Index - Aussie shares from $5 - Read our review
- Pepperstone - Trading education - Read our review
- IC Markets - Experienced and highly regulated - Read our review
- eToro - Social and copy trading platform - Read our review
Year-over-year, the company has seen a revenue increase of 5.49%, growing from 7.11 billion AUD to 7.50 billion AUD, while net income has risen by 29.75% from 393.90 million AUD to 511.10 million AUD. Medibank’s website, where more information can be found, is https://www.medibank.com.au.
Medibank Private Limited (ASX: MPL) Live Chart
Medibank Private Limited (ASX: MPL) Forecast
Medibank Private Ltd. has been analyzed by eight Wall Street analysts, who have a consensus 12-month price target for the company’s stock at AU$3.90. Predictions range from a low of AU$3.60 to a high of AU$4.30. The average price target suggests an approximate 5.17% increase from the company’s most recent closing price of AU$3.71.
Latest Medibank Private Limited News
Medibank Private Limited (ASX: MPL) Performance
Medibank Private Limited (ASX: MPL) Fundamentals
Medibank Private Limited (ASX: MPL) Competitors
Don’t Buy Just Yet
You will want to see this before you make any decisions.
Before you decide which shares to add to your portfolio you might want to take a look at this special report we recently published.
Our experts picked out The 5 best ASX shares to buy in 2024.
We’re giving away this valuable research for FREE.
Click below to secure your copy